Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J Jr., Bers DM, et al
The NHS does not recommend GLP-1 medications for thyroid conditions unless concurrent diabetes or obesity criteria are met
Formulation development focuses on maintaining peptide stability through pH optimization, addition of stabilizing agents, and appropriate packaging systems
(Lausanne) 12 , 735824 (2021)
GLP-1 Plotter uses published pharmacokinetic data from peer-reviewed studies to model drug concentration curves
Future studies would benefit from incorporating additional behavioral paradigms such as the Novel Object Recognition Test to assess recognition memory, the Y-maze to evaluate working memory, or the Barnes maze as an alternative assessment of spatial learning